Dr. Hans Jörg Reinhardt is an Independent Non-Executive Director at Swiss Re AG, an Independent Non-Executive Chairman at Novartis AG, a Council Member at International Federation of Pharmaceutical Manufacturers, a Chairman at Novartis Foundation, a Chairman at Novartis Institutes for Biomedical Research, Inc., a Chairman at Novartis International AG and a Chairman at Novartis, Inc.
He is on the Board of Directors at Swiss Re AG and The Genomics Institute of the Novartis Research Foundation. Dr. Reinhardt was previously employed as a Chairman-Management Board by Bayer HealthCare AG, a Chief Operating Officer by Novartis AG, a Member-Supervisory Board by MorphoSys AG, a Chairman by The Genomics Institute of the Novartis Research Foundation, and a Head-Development by Sandoz Pharmaceuticals AG.
He also served on the board at Lonza Group AG.
He received his doctorate degree from Universität des Saarlandes.